SBX
SynBiotic SE
Stock XETRA – Stock Market Prices, News & Analysis
SynBiotic SE develops and markets dietary supplements and probiotic-based products focused on digestive and immune health.
SynBiotic SE
SBX
SynBiotic SE develops and markets dietary supplements and probiotic-based products focused on digestive and immune health.
Price history of SynBiotic SE
Price history of SynBiotic SE
Performance & Momentum
Strategic Analysis
SynBiotic SE • 2026
SynBiotic SE is positioned in the healthcare and biotechnology sector, targeting a niche market in probiotics and dietary supplements focused on digestive and immune health. Its business model is based on biotechnological innovation to address growing demand for natural and preventive solutions.
- Clear specialization in promising segments of digestive and immune health
- Ability to develop innovative biotechnological solutions in a niche market
- European footprint providing some regulatory and commercial proximity
- Very poor long-term financial and stock market performance history
- Lack of recent news indicating any momentum or turnaround
Momentum is strongly negative, with a pronounced downtrend over several years, reflecting persistent difficulties in regaining market confidence. In the absence of new catalysts, the stock remains fragile and exposed to high risk, requiring heightened caution from any investor.
Similar stocks to SynBiotic SE
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
